Searched for
LACOSAMIDE TABLETS
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...
- It was true in 2008, will be true in 2026, and even in 2036: Hold good stocks for wealth creation; 10 stocks that fit the billThere is enough evidence to show that it is by holding on to stocks for the long term that you ensure wealth creation. Anything can happen ...
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
- Wealth creation is about holding the right stocks and ignoring the noise. 13 ‘right stocks’ with an upside potential of up to 34%Here’s an exercise for investors who entered the markets post-March 2020 (or, even post-2014): Google search (or ask ChatGPT) to list event...
- Glenmark, Sun Pharma, Zydus recall products in USGlenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, according to the ...
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
- It is not always about buying or selling; sometimes, just ‘hold’ stocks: 10 large-caps with an upside potential of up to 49%As the market recovers, what is the more difficult decision to make? To buy or sell stocks? No, the tougher call is which stock to hold on ...
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...
- Look for good quality businesses at relatively lower valuations: 5 large-caps from different sectors with upside potential of up to 44%Our headline says “relatively” lower valuations. Now, “relatively” is used in two contexts. A stock that was trading at a PE of 93 is today...
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
- Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medicationZydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat pa...
- Stocks in the news: Airtel, UPL, Lupin, SBI Card, HUL and auto stocksThe automobile manufacturers, whether two-wheeler or four-wheeler, will report their number of units sold for the month of June 2022.
- Aurobindo Pharma gains as Credit Suisse initiates coverageShares of Aurobindo Pharma surged over 4 per cent in trade on Tuesday as analysts make a bee-line to add the stock to their portfolio.
- Glenmark gets tentative US FDA nod for Lacosamide tabletsGlenmark will market this product upon receiving final approval of its Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg ANDA, it added.
- Aurobindo Pharma gets tentative nod from USFDA for Lacosamide tabletsThis ANDA is at present under litigation in the United States District Court for the District of Delaware, Aurobindo Pharma said.
- UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issueUCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.
- Glenmark confirms patent challenge for its generic versions of VIMPAT in the US CourtGlenmark Generics Ltd confirms that it has filed ANDAs for Lacosamide tablets and oral solution with the US drug authorities with a Paragra...
Load More
